Vera Therapeutics (VERA) Current Assets (2020 - 2026)

Vera Therapeutics (VERA) has 7 years of Current Assets data on file, last reported at $615.8 million in Q1 2026.

• Quarterly Current Assets rose 1.6% year-over-year to $615.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $615.8 million (up 1.6% YoY) and the FY2025 annual result came in at $728.9 million, up 11.93% from the prior year.
• Current Assets slipped to $615.8 million in Q1 2026, from $728.9 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $728.9 million in Q4 2025 to a low of $125.0 million in Q3 2022.
• A 5-year average of $361.7 million and a median of $364.1 million in 2024 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2024 — Current Assets jumped 278.56% — and 2026, when it gained 1.6%.
• Tracing VERA's Current Assets over 5 years: stood at $125.7 million in 2022, then surged by 36.85% to $172.0 million in 2023, then jumped by 278.56% to $651.2 million in 2024, then increased by 11.93% to $728.9 million in 2025, then fell by 15.51% to $615.8 million in 2026.
• The last three Current Assets figures came in at $615.8 million (Q1 2026), $728.9 million (Q4 2025), and $511.3 million (Q3 2025), per Business Quant data.